Viewing StudyNCT04782622



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04782622
Status: UNKNOWN
Last Update Posted: 2021-03-04
First Post: 2021-02-23

Brief Title: The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy
Sponsor: The Affiliated Hospital of Qingdao University
Organization: The Affiliated Hospital of Qingdao University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-03-01
Start Date Type: ESTIMATED
Primary Completion Date: 2022-01-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-03-01
Completion Date Type: ESTIMATED
First Submit Date: 2021-02-23
First Submit QC Date: March 2 2021
Study First Post Date: 2021-03-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-03-02
Last Update Post Date: 2021-03-04
Last Update Post Date Type: ACTUAL